GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Capital Expenditure

BioNeutra Global (TSXV:BGA) Capital Expenditure : C$-0.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

BioNeutra Global's cash flow for capital expenditures for the three months ended in Mar. 2024 was C$0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.02 Mil.

BioNeutra Global Capital Expenditure Historical Data

The historical data trend for BioNeutra Global's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Capital Expenditure Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.08 -0.28 -0.20 -0.02

BioNeutra Global Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - -0.01 -

BioNeutra Global Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNeutra Global (TSXV:BGA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Capital Expenditure
Comparable Companies
NEOE:HOTD XCNQ:MEAT TSXV:VPI TSXV:CYF TSXV:MYLK TSXV:DLC XCNQ:FIT XCNQ:VEGI TSXV:AST XCNQ:PNGA XSWX:NESN KHC XPAR:BN GIS NSE:NESTLEIND SHSE:603288 LSE:ABF SHSE:600887 SZSE:300999 K
Traded in Other Exchanges
BGACF:USA
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
Website
http://www.bioneutra.ca
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Monica Barclay Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines